{"gene":"C1S","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1977,"finding":"Activated C1r cleaves C1s (converting it from single-chain zymogen to two-chain active enzyme), and activated C1s cleaves synthetic lysine ester substrates; C1r does not cleave protein substrates other than C1s, establishing the sequential activation order within C1.","method":"Biochemical characterization of purified C1r and C1s; SDS-PAGE; amino acid composition; esterolytic assays with synthetic substrates","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assays with purified components, replicated across multiple studies","pmids":["869924"],"is_preprint":false},{"year":1977,"finding":"C1s cleaves C2 into C2a (73 kDa) and C2b (34 kDa); C2b retains binding to C4b while C2a is released, demonstrating C2b contains the stable C4b-binding site after C3 convertase decay.","method":"Purified component reconstitution; gel electrophoresis; immunoelectrophoresis; C4b-Sepharose binding assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro cleavage with defined fragment characterization and solid-phase binding assay","pmids":["70787"],"is_preprint":false},{"year":1975,"finding":"C1s forms a stable 1:1 molar SDS/urea-resistant complex with C1 inhibitor (C1-INH); the light chain (serine protease domain) of C1s provides the binding site for C1-INH; native conformation of C1-INH is required for complex formation.","method":"Purified component incubation; SDS-PAGE; size-exclusion chromatography under denaturing conditions; molar ratio analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with defined stoichiometry, replicated in multiple subsequent studies","pmids":["123251"],"is_preprint":false},{"year":1986,"finding":"C1s inhibition by C1-INH follows second-order kinetics (kapp = 6.0 × 10^4 M^-1 s^-1 at 30°C); heparin accelerates inhibition up to 35-fold by binding to all three species (enzyme, inhibitor, complex); Ca2+ has no effect on the rate.","method":"Kinetic analysis of esterolytic activity loss; size-exclusion HPLC under dissociating conditions; fluorescence probes","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal kinetic methods in vitro","pmids":["3091067"],"is_preprint":false},{"year":2000,"finding":"Crystal structure of the C1s catalytic fragment (CCP2-SP) at 1.7 Å reveals a chymotrypsin-like serine protease domain with restricted access to subsidiary substrate binding sites (accounting for narrow specificity) and a CCP2 module oriented perpendicularly to the SP domain surface through a rigid proline/tyrosine-rich interface; CCP2 provides additional substrate recognition sites for C4.","method":"X-ray crystallography at 1.7 Å resolution","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional implications","pmids":["10775260"],"is_preprint":false},{"year":1998,"finding":"Both CCP modules of C1s are required for efficient C4 cleavage: deletion of CCP1 reduces C4-cleaving activity ~70-fold and deletion of both CCPs abolishes it, whereas C2 cleavage is affected mainly by the serine protease domain.","method":"Baculovirus expression of truncated C1s fragments (CCP2-ap-SP, ap-SP); functional assays for C4 and C2 cleavage; comparison with intact C1s","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — recombinant deletion mutant series with functional reconstitution assays","pmids":["9422791"],"is_preprint":false},{"year":2003,"finding":"Crystal structure of the C1s N-terminal interaction domain (CUB1-EGF) at 1.5 Å reveals a Ca2+-dependent head-to-tail homodimer; one Ca2+ bound to each EGF module stabilizes both intra- and inter-monomer interfaces; a second Ca2+ bound to the CUB1 module; this domain mediates both C1r-C1s association and C1q interaction.","method":"X-ray crystallography at 1.5 Å; Ca2+-binding analysis; structural modelling of C1r-C1s heterodimer","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution structure with defined Ca2+-binding sites","pmids":["12788922"],"is_preprint":false},{"year":2009,"finding":"C1q binding to C1s-C1r-C1r-C1s tetramer involves high-affinity sites on C1r CUB1 and CUB2 modules and lower-affinity sites on C1s CUB1; all sites implicate acidic residues that also coordinate Ca2+; six C1q-binding sites total (one per C1q stem) are contributed by the tetramer.","method":"Site-directed mutagenesis of C1r and C1s CUB modules; surface plasmon resonance binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis series combined with quantitative SPR binding measurements","pmids":["19473974"],"is_preprint":false},{"year":2013,"finding":"Crystal structure of C1s-collagen peptide complex shows the C1q collagen stem binds a shallow groove on C1s via a critical lysine side chain contacting Ca2+-coordinating residues, explaining Ca2+-dependent C1q/C1s interaction; C1s also forms a compact ring-shaped head-to-tail tetramer in crystal.","method":"X-ray crystallography of C1s with synthetic collagen-like peptide; structural analysis of C1s tetramer","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple crystal structures in one study with functional validation","pmids":["23922389"],"is_preprint":false},{"year":2013,"finding":"C1q residues LysB61 and LysC58 in the collagen-like stem each play a key role in interaction with the C1s-C1r-C1r-C1s tetramer, likely forming salt bridges with outer acidic Ca2+ ligands of C1r and C1s CUB domains.","method":"Recombinant C1q expression; site-directed mutagenesis of C1q collagen-stem lysines; surface plasmon resonance","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — recombinant mutagenesis with quantitative SPR binding","pmids":["23650384"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of the CUB1-EGF-CUB2 heterodimer of C1r and C1s at defined resolution reveals an antiparallel L-shaped heterodimer stabilized by Ca2+ from each subunit at the interface; contacts involve all three domains of each protease and are more extensive than homodimers, explaining preferential heterocomplex formation.","method":"X-ray crystallography of C1r/C1s CUB1-EGF-CUB2 co-crystal","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — high-resolution co-crystal structure with biophysical validation","pmids":["29311313"],"is_preprint":false},{"year":2013,"finding":"Transition of C1s from zymogen to active form is essential for C4 binding; crystal structure of zymogen C1s (CCP1-CCP2-SP) reveals loops 492–499 and 573–580 sterically block C4 binding in the zymogen, and repositioning of these loops upon activation permits interaction with sulfotyrosine residues on C4; CCP1-CCP2 junction provides an exosite for C4.","method":"Surface plasmon resonance (zymogen vs. active C1s binding to C4); X-ray crystallography of zymogen C1s construct","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus SPR functional validation with defined molecular switch","pmids":["23592783"],"is_preprint":false},{"year":2012,"finding":"Four positively charged residues on the C1s serine protease domain form a catalytic exosite required for efficient C4 cleavage; this exosite coordinates a sulfate ion in crystal structure and interacts with a sulfotyrosine-containing peptide from C4.","method":"Site-directed mutagenesis of SP domain residues; functional C4 cleavage assays; crystallographic sulfate-binding observation; peptide binding assay","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis with functional assay plus structural evidence","pmids":["22855709"],"is_preprint":false},{"year":2005,"finding":"Full substrate specificity of C1s elucidated: S3 (prefers Leu/Val) and S2 (prefers Gly/Ala) subsites dominate specificity beyond P1 (Arg); S2' prefers Leu; a peptide based on top phage display sequence shows best kinetics of any C1s substrate.","method":"Randomized phage display library screening; kinetic peptide substrate assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — combinatorial library plus kinetic validation","pmids":["16169853"],"is_preprint":false},{"year":2005,"finding":"MASP-2 CCP modules confer 21–27-fold higher C4 cleavage efficiency (lower Km) compared to C1s CCP modules; C1s/MASP-2 chimeras with swapped CCP modules retain ability to associate with C1r and C1q in a pseudo-C1 complex and be activated by C1r, demonstrating CCP modules have no direct role in C1r/C1q binding.","method":"Multisite-directed mutagenesis to engineer C1s/MASP-2 chimeras; baculovirus expression; C4 and C2 cleavage assays; hemolytic reconstitution assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis with functional reconstitution and kinetic characterization","pmids":["16227207"],"is_preprint":false},{"year":2000,"finding":"C1s secreted by human fibroblasts cleaves IGFBP-5 but not IGFBP-1 through IGFBP-4; C1r in fibroblast medium undergoes autoactivation and activates C1s; C1-inhibitor blocks IGFBP-5 cleavage, identifying a non-complement substrate of C1s.","method":"Purification from conditioned medium; immunoaffinity chromatography; amino acid sequencing; zymography; inhibitor assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — protein purification with sequence confirmation, immunodepletion, and inhibitor functional assay","pmids":["10982804"],"is_preprint":false},{"year":1990,"finding":"C1s cleaves beta2-microglobulin at Lys-58 in the disulfide loop, generating a two-chain structure; C1 esterase inhibitor blocks this cleavage; this was the first non-complement protein substrate identified for C1s.","method":"In vitro cleavage assay with purified C1s; peptide sequencing; inhibitor assay with C1-INH","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic cleavage with sequence-level identification of cleavage site and inhibitor control","pmids":["2110898"],"is_preprint":false},{"year":2016,"finding":"C1s (as part of C1 complex) proteolytically cleaves HMGB1 into 19 and 12 kDa fragments, diminishing HMGB1's ability to enhance LPS-mediated pro-inflammatory cytokine production from monocytes/macrophages/dendritic cells; mass spectrometry revealed additional intracellular alarmin/autoantigen substrates cleaved by C1s in apoptotic cells.","method":"In vitro cleavage assay with purified C1s and C1 complex; mass spectrometry of treated apoptotic cell proteins; cytokine production assay","journal":"Cell death discovery","confidence":"High","confidence_rationale":"Tier 1–2 — purified protein cleavage assay with functional consequence measurement and MS identification of additional substrates","pmids":["27648302"],"is_preprint":false},{"year":1994,"finding":"C1s is inhibited by the poxvirus serpin SERP-1, which forms a stable complex with C1s (association rate constant 1.3 × 10^3 M^-1 s^-1); heparin does not affect this rate.","method":"Gel analysis of stable complex formation; kinetic inhibition assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro kinetic assay, single lab","pmids":["8416956"],"is_preprint":false},{"year":1992,"finding":"C1s undergoes Ca2+-dependent self-association to a dimer; the monomer has one Ca2+ binding site (K ~3×10^5 M^-1); the dimer has three Ca2+ binding sites, with one high-affinity interfacial site (K ~10^8 M^-1) driving dimerization.","method":"Sedimentation equilibrium ultracentrifugation over a range of protein and Ca2+ concentrations; thermodynamic modeling","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — rigorous biophysical measurement with quantitative thermodynamic model","pmids":["1445906"],"is_preprint":false},{"year":1988,"finding":"The A chain (N-terminal, non-catalytic) of C1s contains all sites responsible for Ca2+-dependent dimerization, formation of the C1r2-C1s2 tetramer, and interaction with C1q; the catalytic B chain is structurally and functionally independent.","method":"Trypsin digestion of C1s to generate A-chain fragment (C1s-A); fast exclusion chromatography; reconstitution assays for C1r2-C1s2 and C1 complex; hemolytic inhibition assay; thermal stability measurement","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays with defined fragment","pmids":["2847785"],"is_preprint":false},{"year":1992,"finding":"Recombinant C1s lacking beta-hydroxyasparagine, sialic acid, and one N-linked carbohydrate chain still reassembles with C1q and C1r to form functional C1 complex and activates C4 and C2, demonstrating these post-translational modifications are not critical for C1s function.","method":"Baculovirus expression; site-directed mutagenesis (Asn159→Gln); reconstitution of C1 complex; hemolytic activity assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — recombinant mutagenesis with full functional reconstitution","pmids":["1533159"],"is_preprint":false},{"year":1997,"finding":"C1-INH complexed with C1s is cleared from circulation via the low-density lipoprotein receptor-related protein (LRP); LRP-deficient fibroblasts fail to degrade C1-INH·C1s complexes; receptor-associated protein (RAP) inhibits in vivo clearance.","method":"Binding assays with HepG2 cells; LRP-knockout fibroblasts; RAP inhibition; in vivo clearance studies in mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout cells plus in vivo clearance with defined receptor","pmids":["9388254"],"is_preprint":false},{"year":1994,"finding":"C1s activates the zymogen of MMP-9 (92 kDa gelatinase), co-localizing with MMP-9 in hypertrophic chondrocytes of the primary ossification center, suggesting coordinated roles in cartilage matrix degradation.","method":"Immunohistochemistry; MMP-9 zymogen activation assay by C1s","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 2–3 — in vitro activation assay plus immunolocalization, single lab","pmids":["8082118"],"is_preprint":false},{"year":1987,"finding":"Cardiolipin vesicles can activate C1s bound to C1q independently of C1r (C1r-independent activation of C1s) in a Ca2+-dependent manner; anti-cardiolipin antibodies block this C1q-mediated cleavage of C1s.","method":"Purified component reconstitution with phospholipid vesicles; SDS-PAGE analysis of C1s chain cleavage; inhibition with antibody","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2 — reconstituted system, single lab","pmids":["3029222"],"is_preprint":false},{"year":1998,"finding":"Anti-C1-INH autoantibodies prevent formation of the stable covalent C1s–C1-INH complex (converting C1-INH to a substrate), but do not dissociate preformed complexes; the autoantibody binding site on C1-INH maps to amino acids 448–459.","method":"SDS-PAGE of complex formation; esterolytic activity assay; peptide competition assay","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Medium","confidence_rationale":"Tier 2 — functional inhibition assay with peptide mapping, single lab","pmids":["9508789"],"is_preprint":false},{"year":2009,"finding":"Polyanions (heparin, dextran sulfate) bind C1s and enhance its proteolytic activity at low concentrations while inhibiting it at higher concentrations; acceleration of C1s–SERPING1 association by polyanions requires interactions with both SERPING1 and C1s.","method":"Kinetic inhibition assays; chimaeric alpha1-antitrypsin/SERPING1 mutant; polyanion binding and activity measurements","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1–2 — in vitro kinetic assays with chimeric inhibitor, single lab","pmids":["19522701"],"is_preprint":false},{"year":2016,"finding":"Heterozygous missense mutations in C1S (at subunit interfaces or inter-domain hinges) cause periodontal Ehlers-Danlos syndrome; mutant C1s is intracellularly retained with mild ER enlargement, linking gain-of-function complement protease variants to connective tissue pathology.","method":"Genetic sequencing of 19 pEDS families; identification of C1S and C1R mutations; cell biology (intracellular retention, ER morphology)","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — large multi-family genetic study with cellular mechanistic follow-up","pmids":["27745832"],"is_preprint":false},{"year":2019,"finding":"Two different pEDS-associated C1S missense mutations (p.Val316del, p.Cys294Arg) both cause secretion of only a truncated ~40 kDa fragment (Fg40) lacking the N-terminal C1q/C1r-interaction domain; Fg40 retains esterolytic activity and HMGB1 cleavage but cannot cleave C4, escaping normal physiological control within the C1 complex.","method":"Stable HEK293-F cell transfection; recombinant protein purification; mass spectrometry; N-terminal sequencing; esterolytic and C4 cleavage assays","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 1–2 — recombinant expression, protein purification, MS, and multiple functional assays","pmids":["31921203"],"is_preprint":false},{"year":2010,"finding":"Mass spectrometry-based chemical modification of lysines shows that upon C1 complex assembly, both C1s CUB1-EGF-CUB2 interaction domains (distant in free tetramer) associate with each other; the C1s serine protease domain is partly positioned inside the C1q cone in the proenzyme C1.","method":"Chemical modification with NHS-acetate; LC-MS/MS comparison of isolated tetramer vs. C1 complex; semi-quantitative label-free analysis of 51/73 lysines","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — comprehensive MS-based structural mapping with multiple orthogonal data points","pmids":["20592021"],"is_preprint":false},{"year":1983,"finding":"Human monocytes synthesize and secrete C1q and C1s; activation by lymphokines from stimulated lymphocyte cultures additionally induces C1r and C1-INH secretion; liver is also a primary site of C1s synthesis.","method":"Pulse-chase metabolic labeling; immunoprecipitation; SDS-PAGE; functional activity assays in primary monocyte cultures","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — direct biosynthesis assay in primary human cells","pmids":["6318736"],"is_preprint":false},{"year":2019,"finding":"C1s knockdown in cutaneous squamous cell carcinoma (cSCC) cells inhibits ERK1/2 and Akt activation, promotes apoptosis, and suppresses xenograft tumor growth and vascularization, defining a tumor-cell-autonomous growth-promoting role for C1s.","method":"siRNA knockdown; Western blotting for pERK1/2 and pAkt; apoptosis assay; xenograft mouse model","journal":"The British journal of dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined signaling phenotype in vivo, single lab","pmids":["31049937"],"is_preprint":false},{"year":2005,"finding":"A novel C1r-like protease (C1r-LP) specifically cleaves pro-C1s into two fragments of identical size to the active C1s chains, providing a C1r-independent means of C1s activation; C1r-LP activity is inhibited by C1-INH.","method":"Recombinant protein expression; protease activity assay against pro-C1s; SDS-PAGE; C1-INH inhibition assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1–2 — recombinant protein cleavage assay with defined substrate, single lab","pmids":["15527420"],"is_preprint":false}],"current_model":"C1s is a modular serine protease that, within the C1 complex (C1q·C1r2·C1s2), is activated by C1r cleavage and then sequentially cleaves complement substrates C4 (requiring both CCP modules and a sulfotyrosine-interacting exosite on the SP domain for recognition) and C2 (requiring mainly the SP domain), with activity regulated by C1-INH forming a covalent 1:1 complex cleared via LRP; outside canonical complement function, C1s also cleaves non-complement substrates including IGFBP-5, beta2-microglobulin, HMGB1, MMP-9 zymogen, and collagen, and gain-of-function C1S mutations causing pEDS produce a truncated fragment that retains protease activity but escapes normal C1-complex regulation."},"narrative":{"teleology":[{"year":1975,"claim":"Establishing how C1s is controlled: demonstration that C1-INH forms a stable 1:1 covalent complex with the C1s light chain (SP domain) resolved the identity and stoichiometry of the primary physiological inhibitor.","evidence":"In vitro reconstitution with purified proteins; SDS-PAGE and size-exclusion chromatography under denaturing conditions","pmids":["123251"],"confidence":"High","gaps":["Mechanism of covalent bond formation not yet resolved at atomic level","In vivo half-life of C1s–C1-INH complex not determined"]},{"year":1977,"claim":"Defining the activation cascade within C1: showing that C1r activates C1s (but not other substrates) and that activated C1s cleaves C2 into C2a and C2b established the sequential C1r→C1s→C2 proteolytic order and the origin of the C3 convertase.","evidence":"Purified component reconstitution; SDS-PAGE; esterolytic assays; gel electrophoresis and C4b-binding assays","pmids":["869924","70787"],"confidence":"High","gaps":["Structural basis of C1r recognition of C1s cleavage site unknown","Rate constants for C1s cleavage of C2 in the context of C4b not measured"]},{"year":1988,"claim":"Functional separation of interaction and catalytic domains: showing that the A chain (N-terminal, non-catalytic) contains all sites for Ca²⁺-dependent dimerization, C1r₂-C1s₂ tetramer formation, and C1q binding, while the B chain (catalytic) is structurally independent, defined C1s as a bipartite molecule.","evidence":"Tryptic fragmentation; size-exclusion chromatography; reconstitution of C1 complex; hemolytic assays","pmids":["2847785"],"confidence":"High","gaps":["Precise domain boundaries for each interaction not mapped at residue level"]},{"year":1990,"claim":"Discovery of non-complement substrates: cleavage of β₂-microglobulin at Lys-58 by C1s, blocked by C1-INH, established that C1s has proteolytic activity beyond complement components, later extended to IGFBP-5, HMGB1, and pro-MMP-9.","evidence":"In vitro cleavage with purified C1s; peptide sequencing; inhibitor controls; subsequent studies with conditioned medium, MS, and cytokine assays","pmids":["2110898","10982804","27648302","8082118"],"confidence":"High","gaps":["Physiological significance of most non-complement cleavages in vivo remains undemonstrated","Full non-complement substrate repertoire not systematically defined"]},{"year":1992,"claim":"Biophysical characterization of Ca²⁺-driven self-association: analytical ultracentrifugation revealed one monomer Ca²⁺ site and a high-affinity interfacial Ca²⁺ site driving dimerization, providing a quantitative thermodynamic framework for C1s assembly.","evidence":"Sedimentation equilibrium ultracentrifugation over a range of protein and Ca²⁺ concentrations with thermodynamic modeling","pmids":["1445906"],"confidence":"High","gaps":["Relationship between homodimer and C1r–C1s heterodimer Ca²⁺ requirements not compared"]},{"year":1998,"claim":"Defining domain requirements for substrate discrimination: deletion of CCP modules reduced C4 cleavage ~70-fold while C2 cleavage was minimally affected, establishing that the CCP modules provide an exosite essential for C4 but not C2 recognition.","evidence":"Baculovirus expression of truncated C1s constructs; functional C4 and C2 cleavage assays","pmids":["9422791"],"confidence":"High","gaps":["Exact residues on CCP modules contacting C4 not yet identified"]},{"year":2000,"claim":"Atomic-resolution view of the catalytic region: the 1.7 Å crystal structure of C1s CCP2-SP revealed a chymotrypsin-fold SP domain with restricted subsidiary site access (explaining narrow specificity) and a rigid CCP2–SP interface, providing the first structural template for inhibitor/drug design.","evidence":"X-ray crystallography at 1.7 Å resolution","pmids":["10775260"],"confidence":"High","gaps":["No structure of C1s in complex with a macromolecular substrate (C4 or C2)"]},{"year":2003,"claim":"Structural basis of Ca²⁺-dependent homodimerization: the 1.5 Å crystal structure of CUB1-EGF revealed a head-to-tail homodimer with Ca²⁺ ions at both EGF and CUB1 modules stabilizing intra- and inter-monomer contacts.","evidence":"X-ray crystallography at 1.5 Å","pmids":["12788922"],"confidence":"High","gaps":["Why the heterodimer with C1r is preferred over the homodimer was not explained"]},{"year":2005,"claim":"Extended specificity profiling: phage display identified S3 (Leu/Val), S2 (Gly/Ala), and S2' (Leu) preferences, and CCP-swap chimeras between C1s and MASP-2 showed CCP modules tune C4 Km 21–27-fold without affecting C1 complex assembly.","evidence":"Randomized phage display library; kinetic peptide assays; domain-swap chimeras with baculovirus expression and hemolytic reconstitution","pmids":["16169853","16227207"],"confidence":"High","gaps":["Structural basis for the CCP-dependent Km difference between C1s and MASP-2 not resolved"]},{"year":2009,"claim":"Mapping C1q-binding sites on the tetramer: mutagenesis and SPR demonstrated that C1s CUB1 contributes lower-affinity C1q-binding sites involving acidic Ca²⁺-coordinating residues, complementing higher-affinity sites on C1r CUB1/CUB2.","evidence":"Site-directed mutagenesis of CUB modules; surface plasmon resonance","pmids":["19473974"],"confidence":"High","gaps":["Relative energetic contributions of individual C1q stems to overall avidity not quantified"]},{"year":2012,"claim":"Identification of a sulfotyrosine-binding exosite: four positively charged SP domain residues coordinate a sulfate ion in the crystal and interact with a C4 sulfotyrosine peptide; mutagenesis confirmed their requirement for efficient C4 cleavage, revealing a post-translational recognition mechanism.","evidence":"Site-directed mutagenesis; functional C4 cleavage assays; crystallographic sulfate binding; peptide binding","pmids":["22855709"],"confidence":"High","gaps":["Whether sulfotyrosine modification of C4 is regulated and thus rate-limiting in vivo is unknown"]},{"year":2013,"claim":"Zymogen-to-active conformational switch for C4 recognition: crystal structure of zymogen C1s CCP1-CCP2-SP showed two loops sterically blocking the C4-binding surface, which reposition upon activation; co-crystal with a collagen peptide showed C1q stem Lys contacts Ca²⁺-coordinating residues on C1s CUB.","evidence":"X-ray crystallography of zymogen and collagen-bound C1s; SPR comparing zymogen vs. active C1s binding to C4","pmids":["23592783","23922389","23650384"],"confidence":"High","gaps":["Full-length C1s structure in the context of the intact C1 complex not yet determined"]},{"year":2016,"claim":"Genetic link to connective tissue disease: heterozygous C1S missense mutations were identified as causative for periodontal Ehlers-Danlos syndrome across 19 families, with mutant C1s showing intracellular retention and ER enlargement.","evidence":"Whole-exome/targeted sequencing of 19 pEDS families; cell biology of mutant protein","pmids":["27745832"],"confidence":"High","gaps":["Mechanism linking complement protease gain-of-function to connective tissue degradation not defined","Effect on C1 complex stoichiometry in patient serum not measured"]},{"year":2018,"claim":"Structural explanation for preferential C1r–C1s heterodimerization: the co-crystal of the C1r–C1s CUB1-EGF-CUB2 heterodimer revealed an antiparallel L-shaped arrangement with more extensive Ca²⁺-mediated interfacial contacts than homodimers.","evidence":"X-ray crystallography of C1r/C1s heterodimeric co-crystal","pmids":["29311313"],"confidence":"High","gaps":["Dynamics of heterodimer formation and any role of chaperones in assembly unknown"]},{"year":2019,"claim":"pEDS mutations produce an unregulated truncated protease: two different pEDS C1S mutations each caused secretion of a ~40 kDa C-terminal fragment (Fg40) lacking the C1q/C1r-interaction domain; Fg40 retained esterolytic and HMGB1-cleaving activity but lost C4 cleavage, explaining how the mutant escapes C1-complex control.","evidence":"Stable HEK293-F transfection; recombinant protein purification; mass spectrometry; N-terminal sequencing; functional assays","pmids":["31921203"],"confidence":"High","gaps":["Whether Fg40 circulates in pEDS patient serum and its in vivo substrates are unknown","Mechanism of aberrant intracellular cleavage generating Fg40 not identified"]},{"year":null,"claim":"A complete structural model of C1s in the context of the fully assembled C1 complex, the precise mechanism by which pEDS-associated C1s protease activity causes connective tissue pathology, and the full physiological relevance of non-complement substrates remain to be established.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or crystal structure of intact C1 complex at high resolution showing C1s positioning","Causal pathway from unregulated C1s protease to periodontal tissue destruction undefined","In vivo significance of C1s cleavage of IGFBP-5, β₂-microglobulin, and MMP-9 not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,5,12,13,15,16,17,23,28]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,13,16]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[15,28,30]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,2,5,7,11,14]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[27,28]}],"complexes":["C1 complex (C1q·C1r₂·C1s₂)","C1s–C1-INH covalent complex"],"partners":["C1R","C1QA","SERPING1","C4A","C2","LRP1"],"other_free_text":[]},"mechanistic_narrative":"C1S encodes a modular serine protease that functions as the catalytic effector of the classical complement C1 complex (C1q·C1r₂·C1s₂), where it is activated by C1r cleavage and then sequentially cleaves complement components C4 and C2 to initiate the classical pathway cascade. The N-terminal CUB1-EGF-CUB2 domains mediate Ca²⁺-dependent homodimerization, heterodimer formation with C1r, and interaction with C1q collagen stems [PMID:12788922, PMID:29311313, PMID:23922389], while the C-terminal CCP1-CCP2-SP region provides substrate recognition: both CCP modules and a sulfotyrosine-interacting exosite on the SP domain are required for efficient C4 cleavage, whereas C2 cleavage depends primarily on the SP domain alone [PMID:9422791, PMID:22855709, PMID:23592783]. C1s activity is regulated by C1-INH, which forms a covalent 1:1 complex with the SP domain that is cleared via LRP [PMID:123251, PMID:9388254]; beyond complement, C1s cleaves non-complement substrates including IGFBP-5, β₂-microglobulin, HMGB1, and pro-MMP-9 [PMID:10982804, PMID:2110898, PMID:27648302, PMID:8082118]. Heterozygous missense mutations in C1S cause periodontal Ehlers-Danlos syndrome (pEDS), producing a truncated ~40 kDa fragment that retains protease activity but escapes C1-complex regulation [PMID:27745832, PMID:31921203]."},"prefetch_data":{"uniprot":{"accession":"P09871","full_name":"Complement C1s subcomponent","aliases":["C1 esterase","Complement component 1 subcomponent s"],"length_aa":688,"mass_kda":76.7,"function":"Component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:11445589, PubMed:16169853, PubMed:417728, PubMed:467643, PubMed:6271784, PubMed:6282646, PubMed:6319179, PubMed:70787, PubMed:9422791). C1S is activated following association of the C1 complex with immunoglobulins (IgG or IgM) complexed with antigens to form antigen-antibody complexes on the surface of pathogens (PubMed:34155115). C1S is cleaved and activated by C1R to generate C1s subcomponent heavy and light chains (PubMed:11445589, PubMed:6271784). C1s subcomponent light chain then cleaves and activates C2 and C4, the next components of the classical complement pathway (PubMed:16169853, PubMed:467643, PubMed:6282646, PubMed:6319179, PubMed:6906228, PubMed:70787, PubMed:9422791) Serine protease component of the complement C1 complex, which catalyzes cleavage and activation of C2 and C4, the next components of the classical complement pathway (PubMed:16169853, PubMed:22949645, PubMed:417728, PubMed:467643, PubMed:6282646, PubMed:6319179, PubMed:70787, PubMed:9422791). Also able to cleave C1 inhibitor (SERPING1) in vitro; additional evidence is however required to confirm this result in vivo (PubMed:16169853). Also cleaves IGFBP5 and thereby inhibits the trophic effects of IGF1 (PubMed:18930415)","subcellular_location":"Secreted; Cell surface","url":"https://www.uniprot.org/uniprotkb/P09871/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/C1S","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/C1S","total_profiled":1310},"omim":[{"mim_id":"617174","title":"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2","url":"https://www.omim.org/entry/617174"},{"mim_id":"613785","title":"COMPLEMENT COMPONENT 1, r SUBCOMPONENT; C1R","url":"https://www.omim.org/entry/613785"},{"mim_id":"613783","title":"COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD","url":"https://www.omim.org/entry/613783"},{"mim_id":"609862","title":"TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6","url":"https://www.omim.org/entry/609862"},{"mim_id":"609342","title":"COBALAMIN-BINDING INTRINSIC FACTOR; CBLIF","url":"https://www.omim.org/entry/609342"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":2663.1}],"url":"https://www.proteinatlas.org/search/C1S"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P09871","domains":[{"cath_id":"2.60.120.290","chopping":"21-133","consensus_level":"high","plddt":91.4317,"start":21,"end":133},{"cath_id":"2.10.25.10","chopping":"137-172","consensus_level":"medium","plddt":81.8661,"start":137,"end":172},{"cath_id":"2.60.120.290","chopping":"176-292","consensus_level":"medium","plddt":93.102,"start":176,"end":292},{"cath_id":"2.10.70.10","chopping":"294-357","consensus_level":"medium","plddt":89.208,"start":294,"end":357},{"cath_id":"2.10.70.10","chopping":"369-423","consensus_level":"high","plddt":90.5131,"start":369,"end":423},{"cath_id":"2.40.10.10","chopping":"443-681","consensus_level":"medium","plddt":87.532,"start":443,"end":681}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P09871","model_url":"https://alphafold.ebi.ac.uk/files/AF-P09871-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P09871-F1-predicted_aligned_error_v6.png","plddt_mean":87.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=C1S","jax_strain_url":"https://www.jax.org/strain/search?query=C1S"},"sequence":{"accession":"P09871","fasta_url":"https://rest.uniprot.org/uniprotkb/P09871.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P09871/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P09871"}},"corpus_meta":[{"pmid":"1460414","id":"PMC_1460414","title":"Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1460414","citation_count":509,"is_preprint":false},{"pmid":"123251","id":"PMC_123251","title":"Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.","date":"1975","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/123251","citation_count":228,"is_preprint":false},{"pmid":"869924","id":"PMC_869924","title":"The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.","date":"1977","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/869924","citation_count":141,"is_preprint":false},{"pmid":"6318736","id":"PMC_6318736","title":"Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.","date":"1983","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/6318736","citation_count":130,"is_preprint":false},{"pmid":"70787","id":"PMC_70787","title":"Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.","date":"1977","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/70787","citation_count":124,"is_preprint":false},{"pmid":"24695853","id":"PMC_24695853","title":"TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24695853","citation_count":121,"is_preprint":false},{"pmid":"2917186","id":"PMC_2917186","title":"Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass.","date":"1989","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2917186","citation_count":118,"is_preprint":false},{"pmid":"10775260","id":"PMC_10775260","title":"Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10775260","citation_count":92,"is_preprint":false},{"pmid":"10878362","id":"PMC_10878362","title":"Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10878362","citation_count":89,"is_preprint":false},{"pmid":"3500856","id":"PMC_3500856","title":"Molecular cloning of cDNA for human complement component C1s. The complete amino acid sequence.","date":"1987","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3500856","citation_count":87,"is_preprint":false},{"pmid":"8912663","id":"PMC_8912663","title":"Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease.","date":"1996","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8912663","citation_count":83,"is_preprint":false},{"pmid":"23922389","id":"PMC_23922389","title":"Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23922389","citation_count":80,"is_preprint":false},{"pmid":"27745832","id":"PMC_27745832","title":"Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27745832","citation_count":78,"is_preprint":false},{"pmid":"8416956","id":"PMC_8416956","title":"Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8416956","citation_count":76,"is_preprint":false},{"pmid":"28980446","id":"PMC_28980446","title":"Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.","date":"2017","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/28980446","citation_count":72,"is_preprint":false},{"pmid":"31049937","id":"PMC_31049937","title":"Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.","date":"2019","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/31049937","citation_count":71,"is_preprint":false},{"pmid":"10982804","id":"PMC_10982804","title":"The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10982804","citation_count":70,"is_preprint":false},{"pmid":"12788922","id":"PMC_12788922","title":"X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12788922","citation_count":69,"is_preprint":false},{"pmid":"19473974","id":"PMC_19473974","title":"Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19473974","citation_count":66,"is_preprint":false},{"pmid":"15210793","id":"PMC_15210793","title":"Structural and functional characterization of complement C4 and C1s-like molecules in teleost fish: insights into the evolution of classical and alternative pathways.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15210793","citation_count":64,"is_preprint":false},{"pmid":"11673555","id":"PMC_11673555","title":"Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11673555","citation_count":63,"is_preprint":false},{"pmid":"15364579","id":"PMC_15364579","title":"The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15364579","citation_count":62,"is_preprint":false},{"pmid":"2459702","id":"PMC_2459702","title":"Human genes for complement components C1r and C1s in a close tail-to-tail arrangement.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2459702","citation_count":60,"is_preprint":false},{"pmid":"9422791","id":"PMC_9422791","title":"Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9422791","citation_count":58,"is_preprint":false},{"pmid":"19477526","id":"PMC_19477526","title":"Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions.","date":"2009","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19477526","citation_count":56,"is_preprint":false},{"pmid":"29311313","id":"PMC_29311313","title":"Structure of the C1r-C1s interaction of the C1 complex of complement activation.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29311313","citation_count":56,"is_preprint":false},{"pmid":"8240317","id":"PMC_8240317","title":"A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8240317","citation_count":53,"is_preprint":false},{"pmid":"23650384","id":"PMC_23650384","title":"Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23650384","citation_count":50,"is_preprint":false},{"pmid":"2110898","id":"PMC_2110898","title":"Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s.","date":"1990","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2110898","citation_count":48,"is_preprint":false},{"pmid":"10364916","id":"PMC_10364916","title":"Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody.","date":"1999","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10364916","citation_count":48,"is_preprint":false},{"pmid":"2026272","id":"PMC_2026272","title":"Complement components C1r/C1s, bone morphogenic protein 1 and Xenopus laevis developmentally regulated protein UVS.2 share common repeats.","date":"1991","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2026272","citation_count":45,"is_preprint":false},{"pmid":"9420617","id":"PMC_9420617","title":"A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s.","date":"1997","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9420617","citation_count":44,"is_preprint":false},{"pmid":"11390518","id":"PMC_11390518","title":"Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11390518","citation_count":44,"is_preprint":false},{"pmid":"3091067","id":"PMC_3091067","title":"Kinetics of interaction of C1 inhibitor with complement C1s.","date":"1986","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3091067","citation_count":44,"is_preprint":false},{"pmid":"8082118","id":"PMC_8082118","title":"Immunolocalization of complement C1s and matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur.","date":"1994","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/8082118","citation_count":43,"is_preprint":false},{"pmid":"2553984","id":"PMC_2553984","title":"Complement genes C1r and C1s feature an intronless serine protease domain closely related to haptoglobin.","date":"1989","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2553984","citation_count":41,"is_preprint":false},{"pmid":"108204","id":"PMC_108204","title":"Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.","date":"1979","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/108204","citation_count":40,"is_preprint":false},{"pmid":"8133044","id":"PMC_8133044","title":"A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8133044","citation_count":39,"is_preprint":false},{"pmid":"18062908","id":"PMC_18062908","title":"Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene.","date":"2007","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18062908","citation_count":37,"is_preprint":false},{"pmid":"20008834","id":"PMC_20008834","title":"Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.","date":"2009","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/20008834","citation_count":37,"is_preprint":false},{"pmid":"7779774","id":"PMC_7779774","title":"Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling.","date":"1995","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7779774","citation_count":37,"is_preprint":false},{"pmid":"9388254","id":"PMC_9388254","title":"C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9388254","citation_count":37,"is_preprint":false},{"pmid":"16169853","id":"PMC_16169853","title":"Elucidation of the substrate specificity of the C1s protease of the classical complement pathway.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16169853","citation_count":36,"is_preprint":false},{"pmid":"25904443","id":"PMC_25904443","title":"An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.","date":"2015","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/25904443","citation_count":35,"is_preprint":false},{"pmid":"16227207","id":"PMC_16227207","title":"Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16227207","citation_count":33,"is_preprint":false},{"pmid":"6604603","id":"PMC_6604603","title":"C1 inactivator-C1s complexes in inflammatory joint disease.","date":"1983","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6604603","citation_count":32,"is_preprint":false},{"pmid":"2847785","id":"PMC_2847785","title":"Domain structure, stability, and interactions of human complement C1s-: characterization of a derivative lacking most of the B chain.","date":"1988","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2847785","citation_count":32,"is_preprint":false},{"pmid":"2834284","id":"PMC_2834284","title":"Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13.","date":"1988","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2834284","citation_count":30,"is_preprint":false},{"pmid":"26769276","id":"PMC_26769276","title":"Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.","date":"2016","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/26769276","citation_count":29,"is_preprint":false},{"pmid":"1533159","id":"PMC_1533159","title":"Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.","date":"1992","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1533159","citation_count":29,"is_preprint":false},{"pmid":"36275687","id":"PMC_36275687","title":"Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36275687","citation_count":28,"is_preprint":false},{"pmid":"3029222","id":"PMC_3029222","title":"Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.","date":"1987","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/3029222","citation_count":28,"is_preprint":false},{"pmid":"7718002","id":"PMC_7718002","title":"Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures.","date":"1995","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/7718002","citation_count":28,"is_preprint":false},{"pmid":"32176765","id":"PMC_32176765","title":"Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32176765","citation_count":27,"is_preprint":false},{"pmid":"1445906","id":"PMC_1445906","title":"Calcium-linked self-association of human complement C1s.","date":"1992","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1445906","citation_count":26,"is_preprint":false},{"pmid":"28926521","id":"PMC_28926521","title":"Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.","date":"2017","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/28926521","citation_count":26,"is_preprint":false},{"pmid":"23592783","id":"PMC_23592783","title":"A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23592783","citation_count":25,"is_preprint":false},{"pmid":"11220628","id":"PMC_11220628","title":"Molecular cloning of the complement (C1r/C1s/MASP2-like serine proteases from the common carp (Cyprinus carpio).","date":"2001","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11220628","citation_count":25,"is_preprint":false},{"pmid":"22855709","id":"PMC_22855709","title":"Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22855709","citation_count":25,"is_preprint":false},{"pmid":"36420270","id":"PMC_36420270","title":"Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36420270","citation_count":25,"is_preprint":false},{"pmid":"6602754","id":"PMC_6602754","title":"Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.","date":"1983","source":"Hoppe-Seyler's Zeitschrift fur physiologische Chemie","url":"https://pubmed.ncbi.nlm.nih.gov/6602754","citation_count":25,"is_preprint":false},{"pmid":"8921412","id":"PMC_8921412","title":"Exon structure of the gene encoding the human mannose-binding protein-associated serine protease light chain: comparison with complement C1r and C1s genes.","date":"1996","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8921412","citation_count":25,"is_preprint":false},{"pmid":"31087560","id":"PMC_31087560","title":"Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.","date":"2019","source":"Biotechnology and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/31087560","citation_count":24,"is_preprint":false},{"pmid":"30635392","id":"PMC_30635392","title":"C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30635392","citation_count":24,"is_preprint":false},{"pmid":"3487577","id":"PMC_3487577","title":"C1s-induced vascular permeability in C2-deficient guinea pigs.","date":"1986","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/3487577","citation_count":24,"is_preprint":false},{"pmid":"3492208","id":"PMC_3492208","title":"Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.","date":"1986","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/3492208","citation_count":23,"is_preprint":false},{"pmid":"7011949","id":"PMC_7011949","title":"Immunofluorescence studies on the subcomponents of the first component of complement (C1): detection of C1q and C1s in different cells of biopsy material and on human as well as on guinea pig peritoneal macrophages.","date":"1981","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/7011949","citation_count":23,"is_preprint":false},{"pmid":"3876244","id":"PMC_3876244","title":"Characterization of C1q, C1s and C-1 Inh synthesized by stimulated human monocytes in vitro.","date":"1985","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/3876244","citation_count":23,"is_preprint":false},{"pmid":"3099750","id":"PMC_3099750","title":"Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.","date":"1986","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/3099750","citation_count":22,"is_preprint":false},{"pmid":"9856483","id":"PMC_9856483","title":"Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene.","date":"1998","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9856483","citation_count":21,"is_preprint":false},{"pmid":"10408360","id":"PMC_10408360","title":"Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex.","date":"1999","source":"Immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10408360","citation_count":21,"is_preprint":false},{"pmid":"6149574","id":"PMC_6149574","title":"Structure and activity of C1r and C1s.","date":"1984","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/6149574","citation_count":21,"is_preprint":false},{"pmid":"1898597","id":"PMC_1898597","title":"Biochemical characterization and tissue distribution of hamster complement C1s.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1898597","citation_count":21,"is_preprint":false},{"pmid":"9508789","id":"PMC_9508789","title":"Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.","date":"1998","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/9508789","citation_count":21,"is_preprint":false},{"pmid":"27648302","id":"PMC_27648302","title":"Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis.","date":"2016","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27648302","citation_count":21,"is_preprint":false},{"pmid":"3874014","id":"PMC_3874014","title":"Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.","date":"1985","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3874014","citation_count":21,"is_preprint":false},{"pmid":"37119056","id":"PMC_37119056","title":"An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.","date":"2023","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/37119056","citation_count":20,"is_preprint":false},{"pmid":"3874650","id":"PMC_3874650","title":"Changes in protein conformation and stability accompany complex formation between human C1 inhibitor and C1-s.","date":"1985","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3874650","citation_count":20,"is_preprint":false},{"pmid":"28882800","id":"PMC_28882800","title":"C1r and C1s from Nile tilapia (Oreochromis niloticus): Molecular characterization, transcriptional profiling upon bacterial and IFN-γ inductions and potential role in response to bacterial infection.","date":"2017","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28882800","citation_count":20,"is_preprint":false},{"pmid":"20592021","id":"PMC_20592021","title":"Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20592021","citation_count":19,"is_preprint":false},{"pmid":"23271740","id":"PMC_23271740","title":"Zebrafish scube1 (signal peptide-CUB (complement protein C1r/C1s, Uegf, and Bmp1)-EGF (epidermal growth factor) domain-containing protein 1) is involved in primitive hematopoiesis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23271740","citation_count":19,"is_preprint":false},{"pmid":"37246953","id":"PMC_37246953","title":"Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.","date":"2023","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/37246953","citation_count":18,"is_preprint":false},{"pmid":"28251805","id":"PMC_28251805","title":"Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.","date":"2017","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/28251805","citation_count":18,"is_preprint":false},{"pmid":"1575792","id":"PMC_1575792","title":"Selective deficiency of C1s associated with a systemic lupus erythematosus-like syndrome. Report of a case.","date":"1992","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/1575792","citation_count":18,"is_preprint":false},{"pmid":"12513694","id":"PMC_12513694","title":"Complement C1r and C1s genes are duplicated in the mouse: differential expression generates alternative isomorphs in the liver and in the male reproductive system.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12513694","citation_count":18,"is_preprint":false},{"pmid":"38085846","id":"PMC_38085846","title":"Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.","date":"2024","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/38085846","citation_count":17,"is_preprint":false},{"pmid":"12192078","id":"PMC_12192078","title":"alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.","date":"2002","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/12192078","citation_count":17,"is_preprint":false},{"pmid":"24218249","id":"PMC_24218249","title":"Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.","date":"2014","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24218249","citation_count":17,"is_preprint":false},{"pmid":"8144914","id":"PMC_8144914","title":"Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8144914","citation_count":17,"is_preprint":false},{"pmid":"12356684","id":"PMC_12356684","title":"Functional characterization of human mannose-binding lectin-associated serine protease (MASP)-1/3 and MASP-2 promoters, and comparison with the C1s promoter.","date":"2002","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12356684","citation_count":16,"is_preprint":false},{"pmid":"12396001","id":"PMC_12396001","title":"C1s, the protease messenger of C1. Structure, function and physiological significance.","date":"2002","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12396001","citation_count":15,"is_preprint":false},{"pmid":"9683269","id":"PMC_9683269","title":"Expression and characterization of a 159 amino acid, N-terminal fragment of human complement component C1s.","date":"1997","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9683269","citation_count":15,"is_preprint":false},{"pmid":"8766156","id":"PMC_8766156","title":"Change of complement C1s synthesis during development of hamster cartilage.","date":"1996","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/8766156","citation_count":15,"is_preprint":false},{"pmid":"3019707","id":"PMC_3019707","title":"Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.","date":"1986","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3019707","citation_count":15,"is_preprint":false},{"pmid":"31921203","id":"PMC_31921203","title":"Two Different Missense C1S Mutations, Associated to Periodontal Ehlers-Danlos Syndrome, Lead to Identical Molecular Outcomes.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31921203","citation_count":14,"is_preprint":false},{"pmid":"9524231","id":"PMC_9524231","title":"Molecular cloning of a cDNA encoding a serine protease homologous to complement C1s precursor from rat C6 glial cells and its expression during glial differentiation.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9524231","citation_count":14,"is_preprint":false},{"pmid":"26241508","id":"PMC_26241508","title":"Characterization of rock bream (Oplegnathus fasciatus) complement components C1r and C1s in terms of molecular aspects, genomic modulation, and immune responsive transcriptional profiles following bacterial and viral pathogen exposure.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26241508","citation_count":14,"is_preprint":false},{"pmid":"19522701","id":"PMC_19522701","title":"Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19522701","citation_count":13,"is_preprint":false},{"pmid":"9211832","id":"PMC_9211832","title":"Coordinated change between complement C1s production and chondrocyte differentiation in vitro.","date":"1997","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/9211832","citation_count":13,"is_preprint":false},{"pmid":"15527420","id":"PMC_15527420","title":"A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15527420","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49190,"output_tokens":7203,"usd":0.127807},"stage2":{"model":"claude-opus-4-6","input_tokens":11005,"output_tokens":3814,"usd":0.225562},"total_usd":0.353369,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1977,\n      \"finding\": \"Activated C1r cleaves C1s (converting it from single-chain zymogen to two-chain active enzyme), and activated C1s cleaves synthetic lysine ester substrates; C1r does not cleave protein substrates other than C1s, establishing the sequential activation order within C1.\",\n      \"method\": \"Biochemical characterization of purified C1r and C1s; SDS-PAGE; amino acid composition; esterolytic assays with synthetic substrates\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays with purified components, replicated across multiple studies\",\n      \"pmids\": [\"869924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1977,\n      \"finding\": \"C1s cleaves C2 into C2a (73 kDa) and C2b (34 kDa); C2b retains binding to C4b while C2a is released, demonstrating C2b contains the stable C4b-binding site after C3 convertase decay.\",\n      \"method\": \"Purified component reconstitution; gel electrophoresis; immunoelectrophoresis; C4b-Sepharose binding assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro cleavage with defined fragment characterization and solid-phase binding assay\",\n      \"pmids\": [\"70787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1975,\n      \"finding\": \"C1s forms a stable 1:1 molar SDS/urea-resistant complex with C1 inhibitor (C1-INH); the light chain (serine protease domain) of C1s provides the binding site for C1-INH; native conformation of C1-INH is required for complex formation.\",\n      \"method\": \"Purified component incubation; SDS-PAGE; size-exclusion chromatography under denaturing conditions; molar ratio analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined stoichiometry, replicated in multiple subsequent studies\",\n      \"pmids\": [\"123251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"C1s inhibition by C1-INH follows second-order kinetics (kapp = 6.0 × 10^4 M^-1 s^-1 at 30°C); heparin accelerates inhibition up to 35-fold by binding to all three species (enzyme, inhibitor, complex); Ca2+ has no effect on the rate.\",\n      \"method\": \"Kinetic analysis of esterolytic activity loss; size-exclusion HPLC under dissociating conditions; fluorescence probes\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal kinetic methods in vitro\",\n      \"pmids\": [\"3091067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of the C1s catalytic fragment (CCP2-SP) at 1.7 Å reveals a chymotrypsin-like serine protease domain with restricted access to subsidiary substrate binding sites (accounting for narrow specificity) and a CCP2 module oriented perpendicularly to the SP domain surface through a rigid proline/tyrosine-rich interface; CCP2 provides additional substrate recognition sites for C4.\",\n      \"method\": \"X-ray crystallography at 1.7 Å resolution\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional implications\",\n      \"pmids\": [\"10775260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Both CCP modules of C1s are required for efficient C4 cleavage: deletion of CCP1 reduces C4-cleaving activity ~70-fold and deletion of both CCPs abolishes it, whereas C2 cleavage is affected mainly by the serine protease domain.\",\n      \"method\": \"Baculovirus expression of truncated C1s fragments (CCP2-ap-SP, ap-SP); functional assays for C4 and C2 cleavage; comparison with intact C1s\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — recombinant deletion mutant series with functional reconstitution assays\",\n      \"pmids\": [\"9422791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure of the C1s N-terminal interaction domain (CUB1-EGF) at 1.5 Å reveals a Ca2+-dependent head-to-tail homodimer; one Ca2+ bound to each EGF module stabilizes both intra- and inter-monomer interfaces; a second Ca2+ bound to the CUB1 module; this domain mediates both C1r-C1s association and C1q interaction.\",\n      \"method\": \"X-ray crystallography at 1.5 Å; Ca2+-binding analysis; structural modelling of C1r-C1s heterodimer\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution structure with defined Ca2+-binding sites\",\n      \"pmids\": [\"12788922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"C1q binding to C1s-C1r-C1r-C1s tetramer involves high-affinity sites on C1r CUB1 and CUB2 modules and lower-affinity sites on C1s CUB1; all sites implicate acidic residues that also coordinate Ca2+; six C1q-binding sites total (one per C1q stem) are contributed by the tetramer.\",\n      \"method\": \"Site-directed mutagenesis of C1r and C1s CUB modules; surface plasmon resonance binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis series combined with quantitative SPR binding measurements\",\n      \"pmids\": [\"19473974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structure of C1s-collagen peptide complex shows the C1q collagen stem binds a shallow groove on C1s via a critical lysine side chain contacting Ca2+-coordinating residues, explaining Ca2+-dependent C1q/C1s interaction; C1s also forms a compact ring-shaped head-to-tail tetramer in crystal.\",\n      \"method\": \"X-ray crystallography of C1s with synthetic collagen-like peptide; structural analysis of C1s tetramer\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple crystal structures in one study with functional validation\",\n      \"pmids\": [\"23922389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"C1q residues LysB61 and LysC58 in the collagen-like stem each play a key role in interaction with the C1s-C1r-C1r-C1s tetramer, likely forming salt bridges with outer acidic Ca2+ ligands of C1r and C1s CUB domains.\",\n      \"method\": \"Recombinant C1q expression; site-directed mutagenesis of C1q collagen-stem lysines; surface plasmon resonance\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant mutagenesis with quantitative SPR binding\",\n      \"pmids\": [\"23650384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of the CUB1-EGF-CUB2 heterodimer of C1r and C1s at defined resolution reveals an antiparallel L-shaped heterodimer stabilized by Ca2+ from each subunit at the interface; contacts involve all three domains of each protease and are more extensive than homodimers, explaining preferential heterocomplex formation.\",\n      \"method\": \"X-ray crystallography of C1r/C1s CUB1-EGF-CUB2 co-crystal\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution co-crystal structure with biophysical validation\",\n      \"pmids\": [\"29311313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Transition of C1s from zymogen to active form is essential for C4 binding; crystal structure of zymogen C1s (CCP1-CCP2-SP) reveals loops 492–499 and 573–580 sterically block C4 binding in the zymogen, and repositioning of these loops upon activation permits interaction with sulfotyrosine residues on C4; CCP1-CCP2 junction provides an exosite for C4.\",\n      \"method\": \"Surface plasmon resonance (zymogen vs. active C1s binding to C4); X-ray crystallography of zymogen C1s construct\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus SPR functional validation with defined molecular switch\",\n      \"pmids\": [\"23592783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Four positively charged residues on the C1s serine protease domain form a catalytic exosite required for efficient C4 cleavage; this exosite coordinates a sulfate ion in crystal structure and interacts with a sulfotyrosine-containing peptide from C4.\",\n      \"method\": \"Site-directed mutagenesis of SP domain residues; functional C4 cleavage assays; crystallographic sulfate-binding observation; peptide binding assay\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis with functional assay plus structural evidence\",\n      \"pmids\": [\"22855709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Full substrate specificity of C1s elucidated: S3 (prefers Leu/Val) and S2 (prefers Gly/Ala) subsites dominate specificity beyond P1 (Arg); S2' prefers Leu; a peptide based on top phage display sequence shows best kinetics of any C1s substrate.\",\n      \"method\": \"Randomized phage display library screening; kinetic peptide substrate assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — combinatorial library plus kinetic validation\",\n      \"pmids\": [\"16169853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MASP-2 CCP modules confer 21–27-fold higher C4 cleavage efficiency (lower Km) compared to C1s CCP modules; C1s/MASP-2 chimeras with swapped CCP modules retain ability to associate with C1r and C1q in a pseudo-C1 complex and be activated by C1r, demonstrating CCP modules have no direct role in C1r/C1q binding.\",\n      \"method\": \"Multisite-directed mutagenesis to engineer C1s/MASP-2 chimeras; baculovirus expression; C4 and C2 cleavage assays; hemolytic reconstitution assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis with functional reconstitution and kinetic characterization\",\n      \"pmids\": [\"16227207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"C1s secreted by human fibroblasts cleaves IGFBP-5 but not IGFBP-1 through IGFBP-4; C1r in fibroblast medium undergoes autoactivation and activates C1s; C1-inhibitor blocks IGFBP-5 cleavage, identifying a non-complement substrate of C1s.\",\n      \"method\": \"Purification from conditioned medium; immunoaffinity chromatography; amino acid sequencing; zymography; inhibitor assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — protein purification with sequence confirmation, immunodepletion, and inhibitor functional assay\",\n      \"pmids\": [\"10982804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"C1s cleaves beta2-microglobulin at Lys-58 in the disulfide loop, generating a two-chain structure; C1 esterase inhibitor blocks this cleavage; this was the first non-complement protein substrate identified for C1s.\",\n      \"method\": \"In vitro cleavage assay with purified C1s; peptide sequencing; inhibitor assay with C1-INH\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic cleavage with sequence-level identification of cleavage site and inhibitor control\",\n      \"pmids\": [\"2110898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"C1s (as part of C1 complex) proteolytically cleaves HMGB1 into 19 and 12 kDa fragments, diminishing HMGB1's ability to enhance LPS-mediated pro-inflammatory cytokine production from monocytes/macrophages/dendritic cells; mass spectrometry revealed additional intracellular alarmin/autoantigen substrates cleaved by C1s in apoptotic cells.\",\n      \"method\": \"In vitro cleavage assay with purified C1s and C1 complex; mass spectrometry of treated apoptotic cell proteins; cytokine production assay\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — purified protein cleavage assay with functional consequence measurement and MS identification of additional substrates\",\n      \"pmids\": [\"27648302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"C1s is inhibited by the poxvirus serpin SERP-1, which forms a stable complex with C1s (association rate constant 1.3 × 10^3 M^-1 s^-1); heparin does not affect this rate.\",\n      \"method\": \"Gel analysis of stable complex formation; kinetic inhibition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinetic assay, single lab\",\n      \"pmids\": [\"8416956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"C1s undergoes Ca2+-dependent self-association to a dimer; the monomer has one Ca2+ binding site (K ~3×10^5 M^-1); the dimer has three Ca2+ binding sites, with one high-affinity interfacial site (K ~10^8 M^-1) driving dimerization.\",\n      \"method\": \"Sedimentation equilibrium ultracentrifugation over a range of protein and Ca2+ concentrations; thermodynamic modeling\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous biophysical measurement with quantitative thermodynamic model\",\n      \"pmids\": [\"1445906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The A chain (N-terminal, non-catalytic) of C1s contains all sites responsible for Ca2+-dependent dimerization, formation of the C1r2-C1s2 tetramer, and interaction with C1q; the catalytic B chain is structurally and functionally independent.\",\n      \"method\": \"Trypsin digestion of C1s to generate A-chain fragment (C1s-A); fast exclusion chromatography; reconstitution assays for C1r2-C1s2 and C1 complex; hemolytic inhibition assay; thermal stability measurement\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with defined fragment\",\n      \"pmids\": [\"2847785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Recombinant C1s lacking beta-hydroxyasparagine, sialic acid, and one N-linked carbohydrate chain still reassembles with C1q and C1r to form functional C1 complex and activates C4 and C2, demonstrating these post-translational modifications are not critical for C1s function.\",\n      \"method\": \"Baculovirus expression; site-directed mutagenesis (Asn159→Gln); reconstitution of C1 complex; hemolytic activity assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant mutagenesis with full functional reconstitution\",\n      \"pmids\": [\"1533159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"C1-INH complexed with C1s is cleared from circulation via the low-density lipoprotein receptor-related protein (LRP); LRP-deficient fibroblasts fail to degrade C1-INH·C1s complexes; receptor-associated protein (RAP) inhibits in vivo clearance.\",\n      \"method\": \"Binding assays with HepG2 cells; LRP-knockout fibroblasts; RAP inhibition; in vivo clearance studies in mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout cells plus in vivo clearance with defined receptor\",\n      \"pmids\": [\"9388254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"C1s activates the zymogen of MMP-9 (92 kDa gelatinase), co-localizing with MMP-9 in hypertrophic chondrocytes of the primary ossification center, suggesting coordinated roles in cartilage matrix degradation.\",\n      \"method\": \"Immunohistochemistry; MMP-9 zymogen activation assay by C1s\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — in vitro activation assay plus immunolocalization, single lab\",\n      \"pmids\": [\"8082118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Cardiolipin vesicles can activate C1s bound to C1q independently of C1r (C1r-independent activation of C1s) in a Ca2+-dependent manner; anti-cardiolipin antibodies block this C1q-mediated cleavage of C1s.\",\n      \"method\": \"Purified component reconstitution with phospholipid vesicles; SDS-PAGE analysis of C1s chain cleavage; inhibition with antibody\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted system, single lab\",\n      \"pmids\": [\"3029222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Anti-C1-INH autoantibodies prevent formation of the stable covalent C1s–C1-INH complex (converting C1-INH to a substrate), but do not dissociate preformed complexes; the autoantibody binding site on C1-INH maps to amino acids 448–459.\",\n      \"method\": \"SDS-PAGE of complex formation; esterolytic activity assay; peptide competition assay\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional inhibition assay with peptide mapping, single lab\",\n      \"pmids\": [\"9508789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Polyanions (heparin, dextran sulfate) bind C1s and enhance its proteolytic activity at low concentrations while inhibiting it at higher concentrations; acceleration of C1s–SERPING1 association by polyanions requires interactions with both SERPING1 and C1s.\",\n      \"method\": \"Kinetic inhibition assays; chimaeric alpha1-antitrypsin/SERPING1 mutant; polyanion binding and activity measurements\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinetic assays with chimeric inhibitor, single lab\",\n      \"pmids\": [\"19522701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Heterozygous missense mutations in C1S (at subunit interfaces or inter-domain hinges) cause periodontal Ehlers-Danlos syndrome; mutant C1s is intracellularly retained with mild ER enlargement, linking gain-of-function complement protease variants to connective tissue pathology.\",\n      \"method\": \"Genetic sequencing of 19 pEDS families; identification of C1S and C1R mutations; cell biology (intracellular retention, ER morphology)\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — large multi-family genetic study with cellular mechanistic follow-up\",\n      \"pmids\": [\"27745832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Two different pEDS-associated C1S missense mutations (p.Val316del, p.Cys294Arg) both cause secretion of only a truncated ~40 kDa fragment (Fg40) lacking the N-terminal C1q/C1r-interaction domain; Fg40 retains esterolytic activity and HMGB1 cleavage but cannot cleave C4, escaping normal physiological control within the C1 complex.\",\n      \"method\": \"Stable HEK293-F cell transfection; recombinant protein purification; mass spectrometry; N-terminal sequencing; esterolytic and C4 cleavage assays\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant expression, protein purification, MS, and multiple functional assays\",\n      \"pmids\": [\"31921203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mass spectrometry-based chemical modification of lysines shows that upon C1 complex assembly, both C1s CUB1-EGF-CUB2 interaction domains (distant in free tetramer) associate with each other; the C1s serine protease domain is partly positioned inside the C1q cone in the proenzyme C1.\",\n      \"method\": \"Chemical modification with NHS-acetate; LC-MS/MS comparison of isolated tetramer vs. C1 complex; semi-quantitative label-free analysis of 51/73 lysines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive MS-based structural mapping with multiple orthogonal data points\",\n      \"pmids\": [\"20592021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Human monocytes synthesize and secrete C1q and C1s; activation by lymphokines from stimulated lymphocyte cultures additionally induces C1r and C1-INH secretion; liver is also a primary site of C1s synthesis.\",\n      \"method\": \"Pulse-chase metabolic labeling; immunoprecipitation; SDS-PAGE; functional activity assays in primary monocyte cultures\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biosynthesis assay in primary human cells\",\n      \"pmids\": [\"6318736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"C1s knockdown in cutaneous squamous cell carcinoma (cSCC) cells inhibits ERK1/2 and Akt activation, promotes apoptosis, and suppresses xenograft tumor growth and vascularization, defining a tumor-cell-autonomous growth-promoting role for C1s.\",\n      \"method\": \"siRNA knockdown; Western blotting for pERK1/2 and pAkt; apoptosis assay; xenograft mouse model\",\n      \"journal\": \"The British journal of dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined signaling phenotype in vivo, single lab\",\n      \"pmids\": [\"31049937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A novel C1r-like protease (C1r-LP) specifically cleaves pro-C1s into two fragments of identical size to the active C1s chains, providing a C1r-independent means of C1s activation; C1r-LP activity is inhibited by C1-INH.\",\n      \"method\": \"Recombinant protein expression; protease activity assay against pro-C1s; SDS-PAGE; C1-INH inhibition assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant protein cleavage assay with defined substrate, single lab\",\n      \"pmids\": [\"15527420\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"C1s is a modular serine protease that, within the C1 complex (C1q·C1r2·C1s2), is activated by C1r cleavage and then sequentially cleaves complement substrates C4 (requiring both CCP modules and a sulfotyrosine-interacting exosite on the SP domain for recognition) and C2 (requiring mainly the SP domain), with activity regulated by C1-INH forming a covalent 1:1 complex cleared via LRP; outside canonical complement function, C1s also cleaves non-complement substrates including IGFBP-5, beta2-microglobulin, HMGB1, MMP-9 zymogen, and collagen, and gain-of-function C1S mutations causing pEDS produce a truncated fragment that retains protease activity but escapes normal C1-complex regulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"C1S encodes a modular serine protease that functions as the catalytic effector of the classical complement C1 complex (C1q·C1r₂·C1s₂), where it is activated by C1r cleavage and then sequentially cleaves complement components C4 and C2 to initiate the classical pathway cascade. The N-terminal CUB1-EGF-CUB2 domains mediate Ca²⁺-dependent homodimerization, heterodimer formation with C1r, and interaction with C1q collagen stems [PMID:12788922, PMID:29311313, PMID:23922389], while the C-terminal CCP1-CCP2-SP region provides substrate recognition: both CCP modules and a sulfotyrosine-interacting exosite on the SP domain are required for efficient C4 cleavage, whereas C2 cleavage depends primarily on the SP domain alone [PMID:9422791, PMID:22855709, PMID:23592783]. C1s activity is regulated by C1-INH, which forms a covalent 1:1 complex with the SP domain that is cleared via LRP [PMID:123251, PMID:9388254]; beyond complement, C1s cleaves non-complement substrates including IGFBP-5, β₂-microglobulin, HMGB1, and pro-MMP-9 [PMID:10982804, PMID:2110898, PMID:27648302, PMID:8082118]. Heterozygous missense mutations in C1S cause periodontal Ehlers-Danlos syndrome (pEDS), producing a truncated ~40 kDa fragment that retains protease activity but escapes C1-complex regulation [PMID:27745832, PMID:31921203].\",\n  \"teleology\": [\n    {\n      \"year\": 1975,\n      \"claim\": \"Establishing how C1s is controlled: demonstration that C1-INH forms a stable 1:1 covalent complex with the C1s light chain (SP domain) resolved the identity and stoichiometry of the primary physiological inhibitor.\",\n      \"evidence\": \"In vitro reconstitution with purified proteins; SDS-PAGE and size-exclusion chromatography under denaturing conditions\",\n      \"pmids\": [\"123251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of covalent bond formation not yet resolved at atomic level\", \"In vivo half-life of C1s–C1-INH complex not determined\"]\n    },\n    {\n      \"year\": 1977,\n      \"claim\": \"Defining the activation cascade within C1: showing that C1r activates C1s (but not other substrates) and that activated C1s cleaves C2 into C2a and C2b established the sequential C1r→C1s→C2 proteolytic order and the origin of the C3 convertase.\",\n      \"evidence\": \"Purified component reconstitution; SDS-PAGE; esterolytic assays; gel electrophoresis and C4b-binding assays\",\n      \"pmids\": [\"869924\", \"70787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of C1r recognition of C1s cleavage site unknown\", \"Rate constants for C1s cleavage of C2 in the context of C4b not measured\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Functional separation of interaction and catalytic domains: showing that the A chain (N-terminal, non-catalytic) contains all sites for Ca²⁺-dependent dimerization, C1r₂-C1s₂ tetramer formation, and C1q binding, while the B chain (catalytic) is structurally independent, defined C1s as a bipartite molecule.\",\n      \"evidence\": \"Tryptic fragmentation; size-exclusion chromatography; reconstitution of C1 complex; hemolytic assays\",\n      \"pmids\": [\"2847785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise domain boundaries for each interaction not mapped at residue level\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Discovery of non-complement substrates: cleavage of β₂-microglobulin at Lys-58 by C1s, blocked by C1-INH, established that C1s has proteolytic activity beyond complement components, later extended to IGFBP-5, HMGB1, and pro-MMP-9.\",\n      \"evidence\": \"In vitro cleavage with purified C1s; peptide sequencing; inhibitor controls; subsequent studies with conditioned medium, MS, and cytokine assays\",\n      \"pmids\": [\"2110898\", \"10982804\", \"27648302\", \"8082118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of most non-complement cleavages in vivo remains undemonstrated\", \"Full non-complement substrate repertoire not systematically defined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Biophysical characterization of Ca²⁺-driven self-association: analytical ultracentrifugation revealed one monomer Ca²⁺ site and a high-affinity interfacial Ca²⁺ site driving dimerization, providing a quantitative thermodynamic framework for C1s assembly.\",\n      \"evidence\": \"Sedimentation equilibrium ultracentrifugation over a range of protein and Ca²⁺ concentrations with thermodynamic modeling\",\n      \"pmids\": [\"1445906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between homodimer and C1r–C1s heterodimer Ca²⁺ requirements not compared\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defining domain requirements for substrate discrimination: deletion of CCP modules reduced C4 cleavage ~70-fold while C2 cleavage was minimally affected, establishing that the CCP modules provide an exosite essential for C4 but not C2 recognition.\",\n      \"evidence\": \"Baculovirus expression of truncated C1s constructs; functional C4 and C2 cleavage assays\",\n      \"pmids\": [\"9422791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact residues on CCP modules contacting C4 not yet identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Atomic-resolution view of the catalytic region: the 1.7 Å crystal structure of C1s CCP2-SP revealed a chymotrypsin-fold SP domain with restricted subsidiary site access (explaining narrow specificity) and a rigid CCP2–SP interface, providing the first structural template for inhibitor/drug design.\",\n      \"evidence\": \"X-ray crystallography at 1.7 Å resolution\",\n      \"pmids\": [\"10775260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of C1s in complex with a macromolecular substrate (C4 or C2)\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Structural basis of Ca²⁺-dependent homodimerization: the 1.5 Å crystal structure of CUB1-EGF revealed a head-to-tail homodimer with Ca²⁺ ions at both EGF and CUB1 modules stabilizing intra- and inter-monomer contacts.\",\n      \"evidence\": \"X-ray crystallography at 1.5 Å\",\n      \"pmids\": [\"12788922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why the heterodimer with C1r is preferred over the homodimer was not explained\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended specificity profiling: phage display identified S3 (Leu/Val), S2 (Gly/Ala), and S2' (Leu) preferences, and CCP-swap chimeras between C1s and MASP-2 showed CCP modules tune C4 Km 21–27-fold without affecting C1 complex assembly.\",\n      \"evidence\": \"Randomized phage display library; kinetic peptide assays; domain-swap chimeras with baculovirus expression and hemolytic reconstitution\",\n      \"pmids\": [\"16169853\", \"16227207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for the CCP-dependent Km difference between C1s and MASP-2 not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapping C1q-binding sites on the tetramer: mutagenesis and SPR demonstrated that C1s CUB1 contributes lower-affinity C1q-binding sites involving acidic Ca²⁺-coordinating residues, complementing higher-affinity sites on C1r CUB1/CUB2.\",\n      \"evidence\": \"Site-directed mutagenesis of CUB modules; surface plasmon resonance\",\n      \"pmids\": [\"19473974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative energetic contributions of individual C1q stems to overall avidity not quantified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of a sulfotyrosine-binding exosite: four positively charged SP domain residues coordinate a sulfate ion in the crystal and interact with a C4 sulfotyrosine peptide; mutagenesis confirmed their requirement for efficient C4 cleavage, revealing a post-translational recognition mechanism.\",\n      \"evidence\": \"Site-directed mutagenesis; functional C4 cleavage assays; crystallographic sulfate binding; peptide binding\",\n      \"pmids\": [\"22855709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether sulfotyrosine modification of C4 is regulated and thus rate-limiting in vivo is unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Zymogen-to-active conformational switch for C4 recognition: crystal structure of zymogen C1s CCP1-CCP2-SP showed two loops sterically blocking the C4-binding surface, which reposition upon activation; co-crystal with a collagen peptide showed C1q stem Lys contacts Ca²⁺-coordinating residues on C1s CUB.\",\n      \"evidence\": \"X-ray crystallography of zymogen and collagen-bound C1s; SPR comparing zymogen vs. active C1s binding to C4\",\n      \"pmids\": [\"23592783\", \"23922389\", \"23650384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length C1s structure in the context of the intact C1 complex not yet determined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genetic link to connective tissue disease: heterozygous C1S missense mutations were identified as causative for periodontal Ehlers-Danlos syndrome across 19 families, with mutant C1s showing intracellular retention and ER enlargement.\",\n      \"evidence\": \"Whole-exome/targeted sequencing of 19 pEDS families; cell biology of mutant protein\",\n      \"pmids\": [\"27745832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking complement protease gain-of-function to connective tissue degradation not defined\", \"Effect on C1 complex stoichiometry in patient serum not measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Structural explanation for preferential C1r–C1s heterodimerization: the co-crystal of the C1r–C1s CUB1-EGF-CUB2 heterodimer revealed an antiparallel L-shaped arrangement with more extensive Ca²⁺-mediated interfacial contacts than homodimers.\",\n      \"evidence\": \"X-ray crystallography of C1r/C1s heterodimeric co-crystal\",\n      \"pmids\": [\"29311313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of heterodimer formation and any role of chaperones in assembly unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"pEDS mutations produce an unregulated truncated protease: two different pEDS C1S mutations each caused secretion of a ~40 kDa C-terminal fragment (Fg40) lacking the C1q/C1r-interaction domain; Fg40 retained esterolytic and HMGB1-cleaving activity but lost C4 cleavage, explaining how the mutant escapes C1-complex control.\",\n      \"evidence\": \"Stable HEK293-F transfection; recombinant protein purification; mass spectrometry; N-terminal sequencing; functional assays\",\n      \"pmids\": [\"31921203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Fg40 circulates in pEDS patient serum and its in vivo substrates are unknown\", \"Mechanism of aberrant intracellular cleavage generating Fg40 not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A complete structural model of C1s in the context of the fully assembled C1 complex, the precise mechanism by which pEDS-associated C1s protease activity causes connective tissue pathology, and the full physiological relevance of non-complement substrates remain to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or crystal structure of intact C1 complex at high resolution showing C1s positioning\", \"Causal pathway from unregulated C1s protease to periodontal tissue destruction undefined\", \"In vivo significance of C1s cleavage of IGFBP-5, β₂-microglobulin, and MMP-9 not demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 5, 12, 13, 15, 16, 17, 23, 28]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 13, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [15, 28, 30]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 2, 5, 7, 11, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [27, 28]}\n    ],\n    \"complexes\": [\n      \"C1 complex (C1q·C1r₂·C1s₂)\",\n      \"C1s–C1-INH covalent complex\"\n    ],\n    \"partners\": [\n      \"C1R\",\n      \"C1QA\",\n      \"SERPING1\",\n      \"C4A\",\n      \"C2\",\n      \"LRP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}